Can You Take Zyrtec While Pregnant?

Editorial desk
“
Reading time: 9 minutes
Information for:
Reading mode:

The short answer on Zyrtec during pregnancy

Available human studies on cetirizine, the active ingredient in Zyrtec, have been reassuring and have not identified higher risks of miscarriage, birth defects, preterm delivery, or low birth weight. These findings do not establish that the medication is risk-free for every pregnancy. Decisions about whether to use cetirizine still require an individualized assessment of potential benefits against any possible risks.

Zyrtec allergy tablets

Because pregnancy involves unique physiological changes and individual health histories, it is important to discuss any changes in how you take cetirizine with a healthcare professional. A clinician can help weigh the impact of managing allergy symptoms against the risks of untreated illness, ensuring that any medication choice aligns with your specific medical needs and pregnancy status.

When deciding to use cetirizine during pregnancy, do you typically consult a healthcare professional?

What Zyrtec is and what it treats

Zyrtec is a brand name for cetirizine, a second-generation antihistamine commonly used to relieve allergy symptoms. It works by blocking histamine, a natural substance the body releases during an allergic reaction that causes sneezing, itching, runny nose, and watery eyes. Because it is less likely to cause drowsiness than older antihistamines, it is frequently chosen for daily management of seasonal allergies and chronic hives.

The medication is available over the counter in the United States and is also sold under other brand names, such as Reactine. It comes in various forms, including tablets, chewable tablets, and liquid solutions. While Zyrtec is widely accessible, its over-the-counter status does not automatically confirm safety for every individual during pregnancy or while breastfeeding.

Identifying the correct product is crucial. The name Zyrtec is associated with several formulations, but only the specific products labeled as “Zyrtec Allergy” or “Zyrtec-D” (which contains a decongestant) may not be appropriate without separate review. Readers should carefully check the active ingredients on the package to confirm it contains only cetirizine. Other products with similar branding may include additional components, such as decongestants or pain relievers, which require distinct safety assessments during pregnancy. Consulting a pharmacist or healthcare provider can help ensure the chosen product contains only the intended antihistamine.

What pregnancy studies show

Research into cetirizine use during pregnancy has focused on specific adverse outcomes, providing the most direct evidence available to clinicians and expectant parents. Several small studies have investigated the risk of miscarriage and found no higher chance of pregnancy loss among those who used the medication compared to those who did not. These findings contribute to the overall reassuring profile of the drug but are part of a broader picture that includes larger cohorts.

The most substantial data come from studies involving more than 1,300 pregnancies exposed to cetirizine. These larger groups did not show an increased chance of birth defects compared to the general population. To put these results in perspective, there is a background chance of a birth defect in any pregnancy of approximately 3%. The absence of a statistically significant increase in exposed groups does not mean that every pregnancy exposed to cetirizine is free from risk, nor does it prove the absence of all risk. It indicates that, within the limits of these studies, the medication was not associated with a detectable rise in congenital anomalies.

Additional research has examined other pregnancy outcomes, such as preterm delivery and low birth weight. Studies involving a smaller number of pregnancies did not find higher chances of these complications with cetirizine exposure. While these results are encouraging, the sample sizes for these specific outcomes were limited, meaning the data cannot rule out small increases in risk that might exist in the broader population.

An important gap in the current evidence concerns long-term developmental outcomes. No studies have been conducted to determine whether prenatal cetirizine exposure affects a child's future behavior or learning abilities. This lack of data means that while immediate birth outcomes appear reassuring, the full scope of potential long-term effects remains unknown. While the available findings are reassuring, they do not establish that cetirizine is risk-free for every pregnancy. Medication decisions still require an individualized benefit-risk assessment, acknowledging both the reassuring data and the inherent limits of current research.

Editor's note

The reassuring birth-outcome data and the absence of long-term neurodevelopmental research are not contradictory. One addresses short-term structural outcomes, while the other asks a different question that simply has not been studied yet.

Take a short knowledge check. Choose one answer for each question and find out how well you understand the topic.

Understanding Zyrtec in Pregnancy

What best describes the pregnancy studies on cetirizine?

Does safety differ by trimester?

The available human pregnancy evidence does not establish a special prohibition for cetirizine use during the first trimester, nor does it support claims that the medication is exclusively safe only after that initial period. Clinical guidance generally avoids trimester-specific restrictions for cetirizine because the observed data do not demonstrate a distinct pattern of risk tied to specific stages of fetal development. While the first trimester is often the period of greatest concern for potential teratogenic effects, the studies examining birth defects and pregnancy loss have not identified a heightened risk specifically linked to early-pregnancy exposure.

Determining the safety of any medication during pregnancy requires an individualized review that considers the timing of exposure alongside other factors, such as the severity of the mother's symptoms and her overall health history. For individuals who took cetirizine before realizing they were pregnant, or who have been using it continuously throughout the first trimester, the recommended approach is to discuss the exposure with a healthcare professional rather than stopping, continuing, or changing the medication solely based on general article information.

A clinician can help evaluate the specific context of the exposure and weigh the benefits of symptom management against any theoretical risks. Because the evidence does not support a trimester-based distinction in safety, decisions should focus on the broader benefit-risk assessment rather than attempting to isolate a “safe window” that is not clearly defined by current research.

Side effects and product-label checks

Identifying the correct formulation is essential because not all products carrying the Zyrtec name contain only cetirizine. Readers must carefully verify the active ingredients listed on the package. While Zyrtec Allergy tablets contain only cetirizine, other products may include additional active ingredients, such as decongestants like pseudoephedrine or phenylephrine. These combination products require a separate safety review during pregnancy because the added components carry different risk profiles that have not been established as safe for this population.

For cetirizine-only products, the US OTC label provides specific safety information regarding drowsiness. Although cetirizine is classified as a second-generation antihistamine with a lower incidence of sedation than older agents, drowsiness can still occur in some individuals. The label advises avoiding alcoholic drinks, as alcohol may increase the sedative effects. It also warns that concomitant use of sedatives or tranquilizers can further increase drowsiness. Because of these potential effects, the label instructs users to exercise caution when driving or operating machinery.

Person using a saline nasal spray to relieve allergy symptoms

The product label also explicitly advises that pregnant or breastfeeding individuals should ask a health professional before using the medication. This caution reflects the need for individualized medical guidance rather than a universal prohibition. When considering combination allergy or cold products, the potential interactions and risks associated with the added ingredients warrant consultation with a pharmacist or pregnancy-care professional to ensure the selected treatment is appropriate for your specific situation.

Non-drug ways to manage allergy symptoms

Managing allergy symptoms during pregnancy often begins with reducing exposure to known triggers. Common environmental allergens include dust mites, pet dander, mold spores, and pollen. Practical steps such as keeping windows closed during high pollen seasons, using allergen-proof covers on bedding, and regularly vacuuming with a HEPA filter can help minimize the amount of allergen present in the home. Showering and changing clothes after spending time outdoors may also help remove pollen from the skin and hair before it settles on furniture or bedding.

Pregnant woman discussing medication with a healthcare professional

For nasal congestion and irritation, saline solutions offer a drug-free method to relieve symptoms. Saline nasal sprays, gels, or rinses can help flush out allergens and mucus from the nasal passages. These products contain only salt and water, making them generally considered safe for use during pregnancy without the risks associated with pharmacological decongestants. Use sterile water or distilled water when preparing homemade saline rinses to avoid the risk of rare but serious infections.

Do you primarily use non-drug methods to manage allergy symptoms during pregnancy?

While non-drug strategies can provide relief, they may not be sufficient for severe symptoms. If lifestyle modifications and saline treatments do not adequately control the allergy symptoms, or if the diagnosis is uncertain, consulting a healthcare professional is recommended. A clinician can help determine the most appropriate management plan, which may include the careful use of medication if the benefits of symptom relief outweigh the potential risks.

When to contact a healthcare professional

Pregnant individuals should consult a healthcare professional before starting, stopping, or changing the dosage of cetirizine. Because pregnancy involves unique physiological changes and potential interactions with other medications, a clinician can help weigh the benefits of managing allergy symptoms against the risks of untreated illness. This consultation is particularly important if symptoms are severe, persistent, or if the diagnosis of allergies is uncertain, as other conditions may require different treatments.

Mother breastfeeding an infant

Individuals with complex medical histories or those taking other prescription medications should also seek professional advice. A healthcare provider can review the full medication list to identify potential interactions and ensure that the chosen allergy treatment aligns with the patient's overall health status and pregnancy progress. This collaborative approach ensures that any medication decisions are based on a comprehensive understanding of the patient's specific needs.

Distinguish between routine allergy management and signs of a severe allergic reaction, or anaphylaxis. Symptoms such as trouble breathing, swelling of the lips, tongue, or throat, or a rapid heartbeat are medical emergencies. These symptoms require immediate emergency assessment and should not be managed by relying on information about routine allergy treatment or over-the-counter medications. In such cases, seeking urgent medical care is essential to protect the health of both the parent and the developing fetus.

Breastfeeding after pregnancy

Cetirizine passes into breast milk in small amounts, but available reports generally describe no problems in breastfed infants. For most nursing parents, the medication is considered compatible with breastfeeding, though individual responses can vary.

If you plan to use cetirizine while breastfeeding, it is helpful to monitor the infant for any changes in behavior or sleep patterns. With repeated use, the infant may experience excessive sleepiness or difficulty waking. If you notice these signs, or any other concerning symptoms, discuss them with the child's healthcare professional.

There has been some suggestion that antihistamine use might reduce milk production, but this effect has not been proven. Cetirizine product labeling in the United States recommends against use while breastfeeding, reflecting a cautious regulatory stance. Expert resources note that the potential benefit to the parent may outweigh the possible risk to the infant. Because the decision involves balancing maternal health needs with infant safety, it is important to discuss the choice with a healthcare professional rather than relying solely on product labels.

Editor's note

The gap between the US product label's recommendation against breastfeeding and MotherToBaby's more balanced guidance reflects different standards: labels default to caution, while expert references weigh potential benefit against possible risk.

Cetirizine

Source: UK Teratology Information Service (UKTIS) / Best Use of Medicines in Pregnancy

Questions and comments

Please do not include passwords, medical record numbers, insurance information, financial information, precise addresses, or other confidential or directly identifying information in your message.